Brain iron deposition in Parkinson's disease imaged using the PRIME magnetic resonance sequence

214Citations
Citations of this article
144Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Iron content of the basal ganglia was investigated in 25 patients with idiopathic Parkinson's disease and 14 matched healthy control subjects using a partially refocused interleaved multiple echo sequence on a 1.5 Tesla MRI system. R2* (1/T2*) and R2' (1/T2') relaxation rates were higher in the substantia nigra of patients with Parkinson's disease, which indicates that iron content is elevated in this region. R2' was lower in the putamen, indicating reduced iron levels; reduction in this region was positively correlated with disease duration. Iron-related oxidative stress may contribute to the neurodegeneration of Parkinson's disease, which may lead to alterations in the iron levels of the striatum. We describe a simple, non-invasive technique for measuring iron content.

Cite

CITATION STYLE

APA

Graham, J. M., Paley, M. N. J., Grünewald, R. A., Hoggard, N., & Griffiths, P. D. (2000). Brain iron deposition in Parkinson’s disease imaged using the PRIME magnetic resonance sequence. Brain, 123(12), 2423–2431. https://doi.org/10.1093/brain/123.12.2423

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free